A Recurrent Neural Network model to predict blood-brain barrier permeability
- PMID: 33010784
- DOI: 10.1016/j.compbiolchem.2020.107377
A Recurrent Neural Network model to predict blood-brain barrier permeability
Abstract
The rapid development of computational methods and the increasing volume of chemical and biological data have contributed to an immense growth in chemical research. This field of study is known as "chemoinformatics," which is a discipline that uses machine-learning techniques to extract, process, and extrapolate data from chemical structures. One of the significant lines of research in chemoinformatics is the study of blood-brain barrier (BBB) permeability, which aims to identify drug penetration into the central nervous system (CNS). In this research, we attempt to solve the problem of BBB permeability by predicting compounds penetration to the CNS. To accomplish this goal: (i) First, an overview is provided to the field of chemoinformatics, its definition, applications, and challenges, (ii) Second, a broad view is taken to investigate previous machine-learning and deep-learning computational models to solve BBB permeability. Based on the analysis of previous models, three main challenges that collectively affect the classifier performance are identified, which we define as "the triple constraints"; subsequently, we map each constraint to a proposed solution, (iii) Finally, we conclude this endeavor by proposing a deep learning based Recurrent Neural Network model, to predict BBB permeability (RNN-BBB model). Our model outperformed other studies from the literature by scoring an overall accuracy of 96.53%, and a specificity score of 98.08%. The obtained results confirm that addressing the triple constraints substantially improves the classification model capability specifically when predicting compounds with low penetration.
Keywords: Blood–brain barrier (BBB) permeability; Chemoinformatics; Dimensionality reduction; Kernel PCA; Quantitative Structure Activity Relationships (QSAR); Recurrent Neural Networks (RNN).
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Similar articles
-
A deep learning approach to predict blood-brain barrier permeability.PeerJ Comput Sci. 2021 Jun 10;7:e515. doi: 10.7717/peerj-cs.515. eCollection 2021. PeerJ Comput Sci. 2021. PMID: 34179448 Free PMC article.
-
Predict drug permeability to blood-brain-barrier from clinical phenotypes: drug side effects and drug indications.Bioinformatics. 2017 Mar 15;33(6):901-908. doi: 10.1093/bioinformatics/btw713. Bioinformatics. 2017. PMID: 27993785 Free PMC article.
-
In silico modeling on ADME properties of natural products: Classification models for blood-brain barrier permeability, its application to traditional Chinese medicine and in vitro experimental validation.J Mol Graph Model. 2017 Aug;75:347-354. doi: 10.1016/j.jmgm.2017.05.021. Epub 2017 Jun 7. J Mol Graph Model. 2017. PMID: 28628860
-
Blood Brain Barrier Permeability Prediction Using Machine Learning Techniques: An Update.Curr Pharm Biotechnol. 2019;20(14):1163-1171. doi: 10.2174/1389201020666190821145346. Curr Pharm Biotechnol. 2019. PMID: 31433750 Review.
-
In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.Drug Des Devel Ther. 2019 Oct 18;13:3591-3605. doi: 10.2147/DDDT.S218708. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31695329 Free PMC article. Review.
Cited by
-
A machine learning and deep learning-based integrated multi-omics technique for leukemia prediction.Heliyon. 2024 Feb 1;10(3):e25369. doi: 10.1016/j.heliyon.2024.e25369. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38352790 Free PMC article.
-
The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery.Pharmaceutics. 2023 Nov 12;15(11):2619. doi: 10.3390/pharmaceutics15112619. Pharmaceutics. 2023. PMID: 38004597 Free PMC article. Review.
-
Emodin derivatives as promising multi-aspect intervention agents for amyloid aggregation: molecular docking/dynamics simulation, bioactivities evaluation, and cytoprotection.Mol Divers. 2023 Sep 22. doi: 10.1007/s11030-023-10733-4. Online ahead of print. Mol Divers. 2023. PMID: 37737959
-
Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases.Nanoscale Adv. 2023 Jul 28;5(17):4354-4367. doi: 10.1039/d3na00180f. eCollection 2023 Aug 24. Nanoscale Adv. 2023. PMID: 37638161 Free PMC article. Review.
-
Could artificial intelligence revolutionize the development of nanovectors for gene therapy and mRNA vaccines?Nano Today. 2022 Dec;47:101665. doi: 10.1016/j.nantod.2022.101665. Epub 2022 Nov 7. Nano Today. 2022. PMID: 37034382 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
